Evidence map›Paper›PMID 30928810›Full record

ArticleNeuroImage. Clinical2019

Bayesian computational markers of relapse in methamphetamine dependence.

Katia M Harlé, Angela J Yu, Martin P Paulus

Abstract read
In one paragraph

Article in NeuroImage. Clinical, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Katia M HarléVA San Diego Healthcare System, United States of America; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States of America. Electronic address: kharle@ucsd.edu.
Angela J YuDepartment of Cognitive Science, University of California San Diego, La Jolla, CA, United States of America.
Martin P PaulusDepartment of Psychiatry, University of California San Diego, La Jolla, CA, United States of America; Laureate Institute for Brain Research, Tulsa, OK, United States of America.

Funding

NEUROBIOLOGY OF TRANSITION TO STIMULANT DEPENDENCER01DA016663 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PAULUS, MARTIN P. · 2004 to 2010
$2.8M
STIMULANT DEPENDENCE: NEURAL MECHANISMS OF RELAPSER01DA018307 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PAULUS, MARTIN P. · 2004 to 2008
$1.3M
Bayesian modeling of mood-driven decision biases for predicting clinical outcomeIK2CX001584 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HARLE, KATIA · 2018 to 2022
–
CSRD VA IK2 CX001584NIDA NIH HHS R01 DA016663NIDA NIH HHS R01 DA018307
6 · The paper itself

Abstract

Methamphetamine use disorder is associated with a high likelihood of relapse. Identifying robust predictors of relapse that have explanatory power is critical to develop secondary prevention based on a mechanistic understanding of relapse. Computational approaches have the potential to identify such predictive markers of psychiatric illness, with the advantage of providing a finer mechanistic explanation of the cognitive processes underlying psychiatric vulnerability. In this study, sixty-two recently sober methamphetamine-dependent individuals were recruited from a 28-day inpatient treatment program, and completed a Stop Signal Task (SST) while undergoing functional magnetic resonance imaging (fMRI). These individuals were prospectively followed for 1 year and assessed for relapse to methamphetamine use. Thirty-three percent of followed participants reported relapse. We found that neural activity associated with two types of Bayesian prediction error, i.e. the difference between actual and expected need to stop on a given trial, significantly differentiated those individuals who remained abstinent and those who relapsed. Specifically, relapsed individuals exhibited smaller neural activations to such Bayesian prediction errors relative to those individuals who remained abstinent in the left temporoparietal junction (Cohen's d = 0.91), the left inferior frontal gyrus (Cohen's d = 0.57), and left anterior insula (Cohen's d = 0.63). In contrast, abstinent and relapsed participants did not differ in neural activation to non-model based task contrasts or on various self-report clinical measures. In conclusion, Bayesian cognitive models may help identify predictive biomarkers of relapse, while providing a computational explanation of belief processing and updating deficits in individuals with methamphetamine use disorder.

Indexed as

Central Nervous System StimulantsInhibition, PsychologicalMethamphetamineAdultAmphetamine-Related DisordersBayes TheoremCerebral CortexExecutive FunctionFemaleFunctional NeuroimagingHumansMagnetic Resonance ImagingMaleMiddle AgedModels, TheoreticalRecurrenceCentral Nervous System StimulantsMethamphetamineBayesian modelInhibitory controlMethamphetamine dependenceRelapseStimulant

Identifiers

PMID30928810
PMCPMC6444286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.